During the past decade, Roanoke Heart Institute conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 8 clinical trials were completed, i.e. on average, 133.3% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 4 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Roanoke Heart Institute" #1 sponsor was "Boehringer Ingelheim" with 4 trials, followed by "Bristol-Myers Squibb" with 2 trials sponsored, "Pfizer" with 2 trials sponsored, "Brigham and Women's Hospital" with 1 trials sponsored and "GE Healthcare" with 1 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Roanoke Heart Institute" #1 collaborator was "Eli Lilly and Company" with 4 trials as a collaborator, "Brigham and Women's Hospital" with 1 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 1 trials as a collaborator, "Pfizer" with 1 trials as a collaborator and "Pharmaceutical Product Development, LLC" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Roanoke Heart Institute" are "Cardiovascular Disease" (3 trials), "Atrial Fibrillation" (2 trials), "Heart Failure" (2 trials), "Arthritis, Rheumatoid" (1 trials) and "Atherosclerotic Cardiovascular Disease" (1 trials). Many other conditions were trialed in "Roanoke Heart Institute" in a lesser frequency.

Most popular intervention types in "Roanoke Heart Institute" are "Drug" (15 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (9 trials), "Empagliflozin" (3 trials), "bococizumab (PF-04950615)" (2 trials), "99mTechnicium (sestamibi or tetrofosmin)" (1 trials) and "Acetylsalicylic acid" (1 trials). Other intervention names were less common.

The vast majority of trials in "Roanoke Heart Institute" are 15 trials for "All" genders.

Currently, there are NaN active trials in "Roanoke Heart Institute". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Roanoke Heart Institute, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Roanoke Heart Institute, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 13 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".